Vijaya Diagnostic acquires Arya Wellness ops for ₹46.20 crore

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Vijaya Diagnostic Centre acquires Arya Wellness Centre's Assam diagnostic ops for ₹46.20 crore
  • Target turnover was ₹26.95 crore in FY25-26, up from ₹25.61 crore in FY24-25
  • Deal structured as a slump sale from NEMRIL HRPL JV, not a related-party transaction
  • Completion expected within 90 days subject to regulatory approvals
powered bylight_fuzz_icon
50686763

*this image is generated using AI for illustrative purposes only.

Vijaya Diagnostic Centre board approved the acquisition of Arya Wellness Centre's diagnostic operations in Assam for ₹46.20 crore through a slump sale on September 11, 2026.

Acquisition details

The transaction involves the purchase of Arya Wellness Centre's diagnostic business in Assam as a going concern through a slump sale structure from NEMRIL HRPL JV (North Eastern Medical Research Institute Limited – Hexagon Research Private Limited JV). The deal is subject to customary closing working capital adjustments and requisite statutory approvals.

Parameter Details
Target Arya Wellness Centre's diagnostic operations
Seller NEMRIL HRPL JV
Location Assam (Guwahati)
Deal value ₹46.20 crore
Transaction structure Slump sale
Approving authority Board of Directors
Approval date September 11, 2026

A slump sale involves the transfer of a business undertaking as a whole, including all its assets and liabilities, for a lump sum consideration without assigning individual values to each component. This structure is commonly used in corporate acquisitions of operational business units.

Target financials

The target entity operates within the Healthcare and Diagnostics industry, providing comprehensive pathology and radiology services on a B2C basis. The following table outlines the historical turnover of the acquired business:

Fiscal Year Turnover
FY25-26 ₹26.95 crore
FY24-25 ₹25.61 crore
FY23-24 ₹22.99 crore

The proposed transaction does not constitute a related party transaction. The promoter, promoter group, and group companies of Vijaya Diagnostic Centre do not hold any interest in the seller entity.

Strategic context

The acquisition extends Vijaya Diagnostic Centre's presence into Assam, adding an established diagnostic network in the northeastern region to its portfolio. The deal was sanctioned at the board level, underscoring the company's commitment to geographic expansion through inorganic growth. The transaction is tentatively expected to be completed within 90 days, or such extended period as may be mutually agreed upon by the parties, subject to the fulfilment of customary conditions precedent specified in the Business Transfer Agreement.

Historical Stock Returns for Vijaya Diagnostic Centre

1 Day5 Days1 Month6 Months1 Year5 Years
+0.21%-0.23%+7.86%+58.92%+42.84%0.0%

How will the integration of Arya Wellness Centre's operations impact Vijaya Diagnostic Centre's EBITDA margins given the current revenue multiple of approximately 1.7x?

What specific synergies or cost-saving measures does management expect to realize from consolidating the Assam diagnostic network within 90 days?

Does this acquisition signal a broader strategic shift for Vijaya Diagnostic Centre to aggressively expand into other northeastern states beyond Assam?

Vijaya Diagnostic Centre
View Company Insights
View All News
like19
dislike

Vijaya Diagnostic Centre hosts investor meet on Sep 10

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Vijaya Diagnostic Centre hosts investor meet on Sep 10
  • Event organized by Emkay Global for analyst discussions
  • Meeting held in person at Bengaluru office
powered bylight_fuzz_icon
49907546

*this image is generated using AI for illustrative purposes only.

Vijaya Diagnostic Centre will host an institutional investor meeting on September 10, 2026. The event, organized by Emkay Global, aims to facilitate discussions with analysts and investors regarding the company's operations and outlook.

The meeting is scheduled for Thursday, September 10, 2026, starting at 11:00 am IST. It will take place at the company's office in JP Nagar, Bengaluru. The format includes both group and one-on-one sessions conducted in person.

Meeting Details

Parameter Details
Date September 10, 2026
Time 11:00 am
Host Emkay Global
Venue Vijaya Diagnostic Centre, JP Nagar, Bengaluru
Mode In Person (Group / One on One)

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Narasimha Raju K A, Chief Financial Officer, signed the intimation letter dated September 2, 2026.

Key Notes

  • Discussions will be based strictly on publicly available information. No unpublished price-sensitive information will be shared during the meetings.
  • The schedule is subject to change due to exigencies on the part of participants or the company.
  • Investors and analysts may approach the company subsequently for clarifications regarding the discussions held during the meeting.

Historical Stock Returns for Vijaya Diagnostic Centre

1 Day5 Days1 Month6 Months1 Year5 Years
+0.21%-0.23%+7.86%+58.92%+42.84%0.0%

What specific growth strategies or expansion plans is Vijaya Diagnostic Centre likely to highlight to institutional investors during the September 10 meeting?

How might the insights shared by Emkay Global influence short-term trading sentiment and valuation metrics for Vijaya Diagnostic Centre's stock?

Will the company address any competitive pressures or regulatory challenges in the Indian diagnostic sector during these investor discussions?

Vijaya Diagnostic Centre
View Company Insights
View All News
like20
dislike

More News on Vijaya Diagnostic Centre

1 Year Returns:+42.84%